Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114Phone+1 617-724-8770
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2012 - 2015- Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2011
Certifications & Licensure
MA State Medical License 2015 - 2026
NH State Medical License 2023 - 2025
ME State Medical License 2020 - 2021- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Pembrolizumab And Lenvatinib In Leptomeningeal Metastases Start of enrollment: 2021 Mar 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 151 citationsLeptomeningeal metastasis from systemic cancer: Review and update on management.Nancy Wang, Mia Bertalan, Priscilla K. Brastianos
Cancer. 2018-01-01 - 80 citationsSingle-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen, Sara M. Tolaney, Nan Lin
Nature Medicine. 2020-08-01 - 43 citationsPhase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Q. Lee, Nancy Wang, Justine V. Cohen
Nature Communications. 2021-10-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
